Fig. 6
From: A generative framework for enhancing drug target interaction prediction in drug discovery
Cross-validation performance metrics over five folds, highlighting the model’s robustness and generalization. Mean ± standard deviation is reported only for VGAN-DTI, which was fully implemented and evaluated via five-fold cross-validation.
